Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study
Background: Pulmonary mucormycosis is a rare life-threatening fungal infection that primarily affects immunocompromised individuals, leading to severe morbidity and high mortality. The delta wave of the COVID-19 pandemic in India witnessed an alarming surge in mucormycosis cases, posing a significan...
Saved in:
Main Authors: | Ashwin Oliver Arul, K. Rajiv Karthik, Devasahayam Jesudas Christopher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Current Medical Issues |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/cmi.cmi_71_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Manifestations, Risk Factors and Management Strategies of COVID-19 Associated Mucormycosis in Tertiary Care Hospital
by: Pankaj Goel, et al.
Published: (2023-04-01) -
Mucormycosis in COVID-19 Patients – A Case Series from a Dental College in South India
by: Annapoorani Sevagaperumal, et al.
Published: (2023-07-01) -
Shift in the profile and prognostic implications in invasive fungal rhinosinusitis: experience of 10 years in a tertiary center
by: Raúl Mellidez-Acosta, et al.
Published: (2025-02-01) -
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
by: Kai Chin Poh, et al.
Published: (2022-07-01) -
Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
by: Mark A. Colantonio, et al.
Published: (2025-01-01)